🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is a multicenter observational study. Patients receive neoadjuva...
Status
Recruiting
Location
Fudan Univeristy Shanghai Cancer Center
Start Date
2024-07-18
Trial ID
NCT06530316
Treatments Being Tested
The reason for this study is to see if the study drug selpercatinib is safe...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham
Start Date
2020-02-11
Trial ID
NCT04211337
Treatments Being Tested
Background: * Medullary thyroid cancer (MTC) represents 5% of thyroid canc...
Status
Terminated
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Start Date
2013-03
Trial ID
NCT01838642
Treatments Being Tested
This study will evaluate the safety and efficacy of durvalumab in combinati...
Status
Unknown
Location
Multiple Locations
Start Date
2020-08-31
Trial ID
NCT04444193
Treatments Being Tested
This phase II LUNG-MAP treatment trial studies how well selpercatinib works...
Status
Active Not Recruiting
Location
Fairbanks Memorial Hospital
Start Date
2020-04-08
Trial ID
NCT04268550
Treatments Being Tested
This is a single arm, nonrandomized, single center clinical study to invest...
Status
Unknown
Location
Hai-Tao Zhao
Start Date
2021-10-01
Trial ID
NCT05048017
Treatments Being Tested
The current study is designed to assess the safety, tolerability, pharmacok...
Status
Completed
Location
GSK Investigational Site
Start Date
2016-06
Trial ID
NCT02798991
Treatments Being Tested
A phase 1/2, first-in-human, open-label study to determine the safety, tole...
Status
Terminated
Location
Local Institution - 2129
Start Date
2019-12-06
Trial ID
NCT04161391
Treatments Being Tested
This phase II, multicenter, single-arm, open-label study evaluates first-li...
Status
Not Yet Recruiting
Location
West China Hospital, Chengdu, Sichuan 610000
Start Date
2026-08
Trial ID
NCT07715565
Treatments Being Tested
This phase I trial studies the side effects and best dose of vandetanib and...
Status
Completed
Location
M D Anderson Cancer Center
Start Date
2012-05-14
Trial ID
NCT01582191
Treatments Being Tested